Precision BioSciences Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 223
Employees
  • Stock Symbol
  • DTIL
Stock Symbol
  • Share Price
  • $14.64
  • (As of Wednesday Closing)

Precision BioSciences General Information

Description

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 302 East Pettigrew Street
  • Dibrell Building, Suite A-100
  • Durham, NC 27701
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision BioSciences Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.64 $14.64 $4.46 - $15.09 $823M 56.2M 1.1M -$2.01

Precision BioSciences Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 206,479 499,171
Revenue 21,961 22,238 10,883 6,484
EBITDA (100,867) (91,645) (45,558) (20,539)
Net Income (106,469) (92,877) (46,037) (21,102)
Total Assets 168,687 235,233 138,600 72,682
Total Debt 10,964 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Precision BioSciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Precision BioSciences‘s full profile, request access.

Request a free trial

Precision BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Precision BioSciences‘s full profile, request access.

Request a free trial

Precision BioSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, A
Biotechnology
Durham, NC
223 As of 2020
00000
0000 0000-00-00
00000000 00000

000000 0

ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000000000000
Cambridge, MA
00 As of 0000
00000
000000000 00000

000000 0

um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Precision BioSciences Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cogent Biosciences Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Beijing, China 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
00000 0000 0000 Venture Capital-Backed Pittsburgh, PA 0 00.000 0000000000 0 00.000
You’re viewing 5 of 38 competitors. Get the full list »

Precision BioSciences Executive Team (16)

Name Title Board Seat Contact Info
Matthew Kane Chief Executive Officer & Founder
Abid Ansari Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
David Thomson Ph.D Chief Operating Officer, Operations
Jeff Smith Ph.D Co-Founder & Chief Technology Officer
Derek Jantz Chief Scientific Officer & Founder
You’re viewing 5 of 16 executive team members. Get the full list »

Precision BioSciences Board Members (8)

Name Representing Role Since
Ben Belldegrun Pontifax Global Food and Agriculture Technology Fund Board Observer 000 0000
Geeta Vemuri Ph.D Baxter Ventures Board Member 000 0000
Geno Germano Self Board Member 000 0000
Shalini Sharp Self Board Member 000 0000
Tony Yao Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Precision BioSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precision BioSciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Precision BioSciences‘s full profile, request access.

Request a free trial